至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Recognition of diazirine-modified O-GlcNAc by human O-GlcNAcase.

Medchemcomm. 2014; 
Rodriguez AC, Kohler JJ.
Products/Services Used Details Operation
Peptide Synthesis … k cat (min −1 ), K m (mM), k cat /K m (mM −1 min −1 ), k cat (min −1 ), K m (mM), k cat /K m (mM −1 min … CKII peptide (Ac-YPGGSTPVSSANMM-NH 2 ; 100 μM; obtained from Genscript) and UDP-GlcNAc or UDP-GlcNDAz (500 μM) were reacted with recombinant OGT (1 μM) in 20 … Get A Quote

摘要

The mammalian O-GlcNAc hydrolase (OGA) removes O-GlcNAc from serine and threonine residues on intracellular glycoproteins. OGA activity is sensitive to N-acyl substitutions to O-GlcNAc, with alkyl diazirine-modified O-GlcNAc (O-GlcNDAz) being completely resistant to removal by OGA. Using homology modeling, we identified OGA residues proximal to the N-acyl position of O-GlcNAc substrate. Mutation of one of these residues, C215, results in mutant enzymes that are able to hydrolytically remove O-GlcNDAz from a model compound. Further, the C215A mutant is capable of removing O-GlcNDAz from a peptide substrate. These results can be used to improve metabolism of O-GlcNAc analogs in cells. In addition, the enzyme spec... More

关键词